Zhenyi Wang

Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

Zhixiang Shen, Guoqiang Chen, Jian-Hua Ni et al. · Blood · 1997 · 1.4K citations

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

Guoqiang Chen, Xuegeng Shi, Wei Tang et al. · PubMed · 1997 · 802 citations

Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients

Chao Niu, Hua Yan, Ting Yu et al. · Blood · 1999 · 626 citations

<i>All-trans</i> retinoic acid/As ₂ O ₃ combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

Zhixiang Shen, Zhanzhong Shi, Jing Fang et al. · Proceedings of the National Academy of Sciences · 2004 · 580 citations · Full text

Hematological Malignancy, Tumor Biology, Pml-rar Alpha +15

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

Guang‐Biao Zhou, Hui Kang, Lan Wang et al. · Blood · 2006 · 197 citations · Full text